EMA Authorised: Brinavess (vernakalant hydrochloride) — Advanz Pharma Limited

View source ↗

Summary

The European Medicines Agency has authorized Brinavess (vernakalant hydrochloride) for atrial fibrillation, with Advanz Pharma Limited as the marketing authoriz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Brinavess (vernakalant hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Atrial Fibrillation. MAH: Advanz Pharma Limited. Decision date: 19/12/2024